Where Innovation Meets Implementation. Experience Europe's New Era of Therapeutic Manufacturing.
Go beyond theory: Cutting-edge science, strategies, & digital tools to accelerate your journey from molecule to market for mAbs, Biologics, & ATMPs.
🚨 £599 Conference Pass – Only 50 Available!
Use code BIOTECHPHARMA599 to secure a main conference pass for just £599, available only to the first 50 qualifying bookings. This offer is limited to active members of pharmaceutical or biotechnology organizations with a therapeutic pipeline.
We're thrilled to welcome to the stage, Thomas Van Cangh, Deputy Head of Unit - DG SANTE at European Commission, who will deliver an exclusive keynote address, bringing invaluable regulatory insights from the highest levels of European healthcare policy directly to the bioprocessing community.
Advance Technologies. Accelerate Production. Transform Bioprocessing.
Ready to go beyond theory? The BioProcess International (BPI) Europe 2026 agenda is where innovation meets implementation. Get the blueprint to master complex modalities, scale your pipeline, and define the future of medicine.
Cell Line Development & Engineering
- Utilise advanced host cell engineering for hard-to-express proteins.
- Apply AI and machine learning for predictive clone selection and lab automation.
- Use multi-omics and NGS to design for stability and de-risk manufacturing.
- Engineer stable producer cell lines for viral vectors and novel modalities.
Cell Culture & Upstream Processing
- Implement digital twins, PAT, and AI for predictive control in multi-modal pipelines.
- Master intensification strategies, including N-1 perfusion and continuous manufacturing.
- Optimise media and raw material strategies to fine-tune product quality.
- Overcome upstream challenges for complex modalities (e.g., exosomes, viral vectors, ADCs).
Downstream Processing
- Adopt a flexible 'toolbox' approach to purify complex and non-platform molecules.
- Explore technologies beyond the column, such as membranes and magnetic beads.
- Integrate continuous downstream processes and automate buffer preparation.
- Embed sustainability with green chemistry principles and bio-based materials.
ATMP Development & Manufacturing
- Tackle the COGS crisis with process intensification and novel raw materials.
- Master phase-appropriate CMC and advanced analytics to de-risk clinical translation.
- Automate autologous manufacturing and scale allogeneic & in-vivo therapies.
- Develop scalable manufacturing for non-viral delivery platforms.
*NEW for 2026* Digital Biomanufacturing & Data-Driven Operations
- Build the data bedrock for Biopharma 4.0 by harmonising data across systems.
- Validate and deploy AI/ML models in a GMP environment for predictive control.
- Build trustworthy digital twins using in-line sensors and physics-informed AI.
- Create a digital roadmap to future-proof your organisation.
Upskill with Pre-Conference Workshops
Deepen your expertise with our full-day workshops designed for practical, hands-on learning.
- Intensified & Continuous Processing
- Mastering Drug Product Formulation & Fill-Finish
- CMC Roadmap
- Advanced Therapy Tech Transfer
Meet Europe's Leaders Preparing You For Tomorrow's Challenges
Our speaker faculty represents the brightest minds from global pharma, innovative biotechs, and pioneering academic institutions. Expect visionary keynotes, deep-dive case studies, and practical insights designed to help you go beyond theory. Learn directly from the experts who are turning today's innovations into tomorrow's reality.
BPI Europe Returns to Vienna - Where Science Meets Opportunity
Join us as we return to Vienna, a globally recognized meeting destination and one of Europe's premier life science hubs. The city is home to the renowned Vienna BioCenter, a nexus of academic research and over 50 innovative biotech companies, alongside industry leaders like Boehringer Ingelheim, Takeda and Novartis. This powerful combination of scientific excellence, seamless accessibility, and rich cultural heritage provides the ideal backdrop to connect with global pioneers and forge the collaborations that will drive the future of bioprocessing.
Get a feel for the buzz on-site!
BioProcess International Europe gathers today's top scientists and biopharma suppliers working across the entire spectrum of biopharmaceutical development and production.
Watch the highlight video and see why we are Europe's leading bioprocessing event for mAbs, novel modalities & biologics. Join us in Vienna, Austria in 2026 for another exceptional gathering of industry leaders.
Audience Breakdown
%
of attendees are coming from top Pharma & Biotech companies
of the top 20 pharma companies are sending representatives
%
of attendees hold VP-level and higher titles, fostering high-level discussions
Engage Qualified Bioprocessing Decision-Makers!
Whether you're increasing your company profile, launching a new product, or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us directly at Partners@informaconnectls.com
Get the Latest Event Updates
FAQs
When and where is BioProcess International Europe 2026 taking place?
BioProcess International Europe (BPI Europe) will take place on April 27-30, 2026, at the Vienna Congress & Convention Center, Vienna, Austria.
What is BioProcess International Europe (BPI Europe)?
BPI Europe is Europe's premier bioprocessing conference and exhibition that brings together scientists, innovators, and industry leaders to advance biologics manufacturing. The event focuses on cutting-edge science, strategies, & digital tools to accelerate your journey from molecule to market for mAbs, Biologics, & ATMPs.
Who organizes BioProcess International Europe?
BPI Europe is organized by Informa Connect, a division of Informa PLC. Find out more about Informa’s Life Science events here.
What are the main focus areas for BioProcess International Europe 2026?
BioProcess International (BPI) Europe 2026 will focus on several key areas, across 5 tracks and 4 pre-conference workshops, including:
Cell Line Development: Engineering high-producing cell lines for complex biologics with AI and CRISPR.
Upstream Processing: Intensifying upstream processes and de-risking scale-up with digital tools.
Downstream Processing: Purifying novel molecules with continuous processes and next-gen membrane tech.
ATMP Manufacturing: Lowering COGs and reaching patients through automation and advanced analytics.
Digital Biomanufacturing: Building the smart factory by integrating data and implementing AI-driven digital twins.
Who will be speaking at BioProcess International Euope 2026?
View participating experts, industry leaders, scientists, and trailblazers on our Speaker Page here.
Are there sponsorship opportunities available?
Custom sponsorship opportunities are available to help you reach your business objectives, whether you're looking to generate quality leads, showcase thought leaders, or reinforce your brand. For more information, contact partners@informaconnectls.com.
View the Sponsor Prospectus, Floorplan, and more on our Sponsors & Exhibitors page.
What is the difference between BioProcess International events and the BioProcess International publication?
BioProcess International operates as both an event series and a media publication, each serving distinct purposes within the biopharmaceutical industry.
BioProcess International events are industry-leading conferences and exhibitions that bring together bioprocessing professionals for in-person knowledge exchange and networking. Our events include:
- BioProcess International (BPI) : Held in Boston, US and part of Biotech Week Boston, focuses on established biomanufacturing, regulatory deep-dives and digitalization.
- BioProcess International US West (BPI West): This event is held in San Diego, California, US, and emphasizes emerging technologies and West Coast innovation
- BioProcess International Asia (BPI Asia) : Held in Kyoto, Japan, features advances in biologics production for the Asian market.
- BioProcess International Europe (BPI Europe): Held in Vienna, Austria, for 2026, focuses on bioprocessing mastery for European market.
BioProcess International Publication
BioProcess International is a monthly, controlled-circulation magazine, providing the latest, peer-reviewed information on the development, scale-up, and manufacture of biotherapeutics and biodiagnostics, reaching 35,000+ print subscribers and 50,000+ digital readers globally.
Both the events and publication are part of Informa Connect, a division of Informa PLC.